-
COVID-19 vaccination strategies and deployment in the EU/EEA
08 September, 2022
Nearly three-quarters of the EU/EEA population have completed the primary vaccination course...COVID-19
-
European statement on COVID-19 booster vaccination with Omicron bivalent adapted vaccines
06 September, 2022
EMA and ECDC advice for bivalent COVID-19 booster vaccination...COVID-19
-
Inhaled COVID-19 vaccine receives approval
China // 05 September, 2022
Inhaled COVID-19 vaccine approved in China...COVID-19
-
Omicron-adapted bivalent Moderna vaccine authorised as booster dose
Canada // 02 September, 2022
Moderna’s bivalent COVID-19 vaccine to be used as a booster dose...COVID-19
-
WHO COVID-19 Weekly Reports August 2022
31 August, 2022
WHO summary of COVID-19 global activity suggests...COVID-19
-
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections
31 August, 2022
A recent study found that prior immunity reduces one's risk of transmission...COVID-19
-
AstraZeneca's Evusheld gets EUA
Japan // Australia // United Kingdom // United States // 30 August, 2022
Drug approved to prevent COVID-19 in some people...COVID-19
-
Report on preparing for future pandemics including priority viruses
Australia // 29 August, 2022
Priority virus families include Japanese Encephalitis and Hendra....General Articles, COVID-19, Seasonal Flu
-
Swissmedic approves Moderna bivalent COVID-19 booster vaccine
Switzerland // 29 August, 2022
The newly authorised booster dose targets Omicron variant BA.1...COVID-19
-
Ordering at-home testing kits from U.S. government to be suspended
United States // 29 August, 2022
On 2 September, ordering through the U.S. government website will be suspended...COVID-19
-
WHO initiates mRNA vaccine technology transfer to African nations
29 August, 2022
The World Health Organization (WHO) will tranfer mRNA vaccine technology to at least six African nations...COVID-19
-
Novavax approved for use in 12 to 17 year olds
Australia // 29 August, 2022
Roll out commences 5 September ...COVID-19
-
ECDC COVID-19 overview report for week 33 published
26 August, 2022
Week 33 ECDC COVID-19 report published...COVID-19
-
Vaccine Update – Vaccinations for 5 to 11 year olds begins
Bangladesh // 25 August, 2022
Updates on vaccination in Bangladesh...COVID-19
-
COVID-19 incubation shortened over time
22 August, 2022
Decreased from 5 days to 3.4 days...COVID-19
-
Vaccine Update – Novavax expanded use to include 12-17 year olds
New Zealand // 21 August, 2022
The vaccine can be used as a primary series in those aged 12 and older ....COVID-19
-
First booster for children aged 5 - 11 years announced
Canada // 19 August, 2022
Children aged 5 years and older eligible for first booster...COVID-19
-
ECDC weekly COVID-19 Country overview for week 32
19 August, 2022
ECDC Weekly COVID-19 update for week 32...COVID-19
-
WHO recommends Valneva COVID-19 vaccine, second booster doses
18 August, 2022
Valneva's inactivated whole-virus vaccine consists of two doses...COVID-19
-
Risk of neurological and psychiatric illnesses after COVID-19 diagnosis
18 August, 2022
Risk of neurological and psychiatric illnesses persists within 2 years of infected with COVID-19COVID-19